Cas:13183-68-1 2-methylpropane-2-d manufacturer & supplier

We serve Chemical Name:2-methylpropane-2-d CAS:13183-68-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-methylpropane-2-d

Chemical Name:2-methylpropane-2-d
CAS.NO:13183-68-1
Synonyms:2-methylpropane-2-d1;Isobutan-2-d;ISOBRUCEINE-B;MFCD01074053;2-deuterio-2-methyl-propane;2-Methyl-2-deutero-propan;isobutane-2-d1;2-Deuterio-2-methyl-propan;isobrucein-B
Molecular Formula:C4H9D
Molecular Weight:59.12840
HS Code:

Physical and Chemical Properties:
Melting point:160ºC(lit.)
Boiling point:12ºC(lit.)
Density:2.01 (21ºC. vs air)
Index of Refraction:1.352
PSA:
Exact Mass:59.08450
LogP:1.66230

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1969 2
Packing Group:


Contact us for information like 2-methylpropane-2-d1 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,isobrucein-B physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Isobutan-2-d Use and application,isobutane-2-d1 technical grade,usp/ep/jp grade.


Related News: ADA-SCID is caused by a gene mutation that affects a critical protein called adenosine deaminase, which is needed to keep toxins in the body from destroying disease-fighting white blood cells. ethyl 2-amino-1,3-benzothiazole-7-carboxylate hydrobromide manufacturers This has led to them being evaluated as alternatives to traditional metal catalysts for driving various chemical transformations, where they have demonstrated huge success. Some of the first enzyme classes used as tools for organic synthesis were hydrolases (e.g. amidases, esterases, and lipases), alcohol dehydrogenases, and ketoreductases. 8-((3-hydroxy-13,24,34,43,53,63-hexaoxin-2-yl)oxy)-1H-13,24,33,44,53,64,73,84,94-pentaoxolo[1,5]hexaoxine-1,2,6-triol suppliers Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial. (1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl) diphenyl phosphate vendor & factory.